These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17725100

  • 1. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.
    Ovali E, Dikmen T, Sonmez M, Yilmaz M, Unal A, Dalbasti T, Kuzeyli K, Erturk M, Omay SB.
    J Exp Clin Cancer Res; 2007 Jun; 26(2):209-14. PubMed ID: 17725100
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomas.
    Katano M, Morisaki T, Koga K, Nakamura M, Onishi H, Matsumoto K, Tasaki A, Nakashima H, Akiyoshi T, Nakamura M.
    Anticancer Res; 2005 Jun; 25(6A):3771-6. PubMed ID: 16302738
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y, Itoh T, Nukaya I, Kawashima I, Okugawa K, Yano Y, Yamamoto Y, Naitoh K, Shimizu K, Imura K, Fuji N, Fujiwara H, Ochiai T, Itoi H, Sonoyama T, Hagiwara A, Takesako K, Yamagishi H.
    Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells.
    Matsumoto A, Haraguchi K, Takahashi T, Azuma T, Kanda Y, Tomita K, Kurokawa M, Ogawa S, Takahashi K, Chiba S, Kitamura T.
    Int J Urol; 2007 Apr; 14(4):277-83. PubMed ID: 17470153
    [Abstract] [Full Text] [Related]

  • 5. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD, Bellone S, Palmieri M, Ravaggi A, Romani C, Tassi R, Roman JJ, Burnett A, Pecorelli S, Cannon MJ.
    Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H, Zhou FJ, Wang QJ, Qin ZK, Huang LX, Liu ZW, Han H, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cell vaccination of patients with metastatic colorectal cancer.
    Burgdorf SK.
    Dan Med Bull; 2010 Sep; 57(9):B4171. PubMed ID: 20816019
    [Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.
    Yamanaka R, Homma J, Yajima N, Tsuchiya N, Sano M, Kobayashi T, Yoshida S, Abe T, Narita M, Takahashi M, Tanaka R.
    Clin Cancer Res; 2005 Jun 01; 11(11):4160-7. PubMed ID: 15930352
    [Abstract] [Full Text] [Related]

  • 9. Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer.
    Kao JY, Zhang M, Chen CM, Chen JJ.
    Immunol Lett; 2005 Nov 15; 101(2):154-9. PubMed ID: 15993950
    [Abstract] [Full Text] [Related]

  • 10. Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.
    Hegmans JP, Veltman JD, Lambers ME, de Vries IJ, Figdor CG, Hendriks RW, Hoogsteden HC, Lambrecht BN, Aerts JG.
    Am J Respir Crit Care Med; 2010 Jun 15; 181(12):1383-90. PubMed ID: 20167848
    [Abstract] [Full Text] [Related]

  • 11. Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.
    Loveland BE, Zhao A, White S, Gan H, Hamilton K, Xing PX, Pietersz GA, Apostolopoulos V, Vaughan H, Karanikas V, Kyriakou P, McKenzie IF, Mitchell PL.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):869-77. PubMed ID: 16467101
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
    Kamigaki T, Kaneko T, Naitoh K, Takahara M, Kondo T, Ibe H, Matsuda E, Maekawa R, Goto S.
    Anticancer Res; 2013 Jul 01; 33(7):2971-6. PubMed ID: 23780988
    [Abstract] [Full Text] [Related]

  • 13. Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients.
    Bedrosian I, Mick R, Xu S, Nisenbaum H, Faries M, Zhang P, Cohen PA, Koski G, Czerniecki BJ.
    J Clin Oncol; 2003 Oct 15; 21(20):3826-35. PubMed ID: 14551301
    [Abstract] [Full Text] [Related]

  • 14. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
    Dessureault S, Noyes D, Lee D, Dunn M, Janssen W, Cantor A, Sotomayor E, Messina J, Antonia SJ.
    Ann Surg Oncol; 2007 Feb 15; 14(2):869-84. PubMed ID: 17103257
    [Abstract] [Full Text] [Related]

  • 15. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B, Tröger A, Glouchkova L, Körholz D, Göbel U, Dilloo D.
    Klin Padiatr; 2004 Feb 15; 216(3):176-82. PubMed ID: 15175963
    [Abstract] [Full Text] [Related]

  • 16. [Reduction of immunosuppression and shift to Th1 response by tumor-DC (dendritic cells) fusion vaccine].
    Iinuma H, Okinaga K, Fukushima R, Inaba T, Iwasaki K, Arai T, Tamura J, Kumagai H.
    Gan To Kagaku Ryoho; 2004 Oct 15; 31(11):1640-2. PubMed ID: 15553669
    [Abstract] [Full Text] [Related]

  • 17. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.
    Soleimani A, Berntsen A, Svane IM, Pedersen AE.
    Scand J Immunol; 2009 Nov 15; 70(5):481-9. PubMed ID: 19874553
    [Abstract] [Full Text] [Related]

  • 18. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun 15; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 19. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J, Wang CL, Hao XS.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2785-90. PubMed ID: 18167273
    [Abstract] [Full Text] [Related]

  • 20. Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine.
    Burgdorf SK, Fischer A, Myschetzky PS, Munksgaard SB, Zocca MB, Claesson MH, Rosenberg J.
    Oncol Rep; 2008 Dec 23; 20(6):1305-11. PubMed ID: 19020707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.